Bisacodyl and Kyprolis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bisacodyl (bisacodyl) and Kyprolis (carfilzomib). Common drug interactions include haematochezia among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Bisacodyl and Kyprolis. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Bisacodyl?

Bisacodyl has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 18,852 Bisacodyl users. Check the latest studies of Bisacodyl.

What is Kyprolis?

Kyprolis has active ingredients of carfilzomib. It is often used in multiple myeloma. eHealthMe is studying from 15,080 Kyprolis users. Check the latest studies of Kyprolis.



On Jul, 13, 2026

14 people who take Bisacodyl and Kyprolis together, and have interactions are studied.

Bisacodyl and Kyprolis drug interactions.

What are the common drug interactions of Bisacodyl and Kyprolis, by gender? *:

female:

  1. Haematochezia (passage of stools containing blood)
  2. Microangiopathic haemolytic anaemia (anaemia due to inability of bone marrow to compensate the premature destruction of red blood cells)
  3. Renal failure (kidney dysfunction)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Thrombosis (formation of a blood clot inside a blood vessel)
  6. Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Cystitis (inflammation of the wall of the bladder)
  3. Nausea (feeling of having an urge to vomit)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
  7. Fall
  8. Fatigue (feeling of tiredness)
  9. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  10. Vision blurred

What are the common drug interactions of Bisacodyl and Kyprolis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Microangiopathic haemolytic anaemia (anaemia due to inability of bone marrow to compensate the premature destruction of red blood cells)
  2. Renal failure (kidney dysfunction)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)

60+:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Cystitis (inflammation of the wall of the bladder)
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
  6. Thrombosis (formation of a blood clot inside a blood vessel)
  7. Vision blurred
  8. Fall
  9. Fatigue (feeling of tiredness)
  10. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

What are the existing conditions these people have? *

  1. Pneumonia: 1 person, 7.14%
  2. Pain: 1 person, 7.14%
  3. Nausea And Vomiting: 1 person, 7.14%
  4. Nausea (feeling of having an urge to vomit): 1 person, 7.14%
  5. Dyspnea (difficult or laboured breathing): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Bisacodyl and Kyprolis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bisacodyl and Kyprolis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bisacodyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kyprolis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bisacodyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kyprolis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bisacodyl and carfilzomib (the active ingredients of Bisacodyl and Kyprolis, respectively), and Bisacodyl and Kyprolis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: